跳至主要内容
临床试验/ISRCTN40939838
ISRCTN40939838进行中(未招募)未知

Evaluation of specific unmet needs in the current clinical practice of multiple sclerosis: characterization of different profiles of relapsing multiple sclerosis patients defined by disease activity and patient-reported outcomes (Profile RMS)

Roche Pharma AG0 个研究点目标入组 1,250 人开始时间: 2021年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
1,250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. RRMS or rSPMS, diagnosed by revised McDonald 2010 criteria
  • 2. Treatment naïve participants or participants without current treatment or participants being treated with an approved DMT according to the respective summary of product characteristics (SPC)

排除标准

  • 1. Participation in an interventional study or in NIS Confidence (ML39632)
  • 2. Participants not receiving treatment for MS with the studied DMTs according to the standard of care and in line with the current SPC
  • 3. Off-label use of any medication

研究者

相似试验

A study to evaluate specific unmet needs in the... | 临床试验